Lake Street upgraded Evolv (EVLV) to Buy from Hold with a price target of $9, up from $5.50, after the company reported a beat on both revenue and AEBITDA for Q2. The firm, which raised its 2025 revenue and AEBITDA forecasts, feels “there is a strengthening of tailwinds on the business.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVLV:
- Evolv reinstated with a Buy at TD Cowen
- Evolv Technology Reports Strong Revenue Growth Amid Losses
- Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
- Evolv Technologies Announces Resignation of Chief Innovation Officer
- Evolv reports Q2 adjusted EPS (2c) vs (7c) last year